Ftse Mib
34.362,51
-0,31%
DAX
18.619,70
-0,36%
S&P 500
5.267,84
-0,74%
NASDAQ
16.736,03
0,00%
Bitcoin
67.479,59
-0,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gemphire Therapeutics Inc (GEMP) Gemphire Therapeutics Inc (GEMP) Notizie

GEMP

Gemphire Therapeutics (GEMP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GEMP
DataOraFonteTitoloSimboloCompagnia
31/12/201912:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201917:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201917:08GlobeNewswire Inc.Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
06/12/201922:25Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
06/12/201914:43GlobeNewswire Inc.Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201915:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
07/11/201912:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
06/11/201915:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
04/11/201922:27Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/09/201912:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201923:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
05/08/201914:22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
26/07/201922:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
24/07/201922:01GlobeNewswire Inc.Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease CompanyNASDAQ:GEMPGemphire Therapeutics Inc
16/07/201922:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GEMPGemphire Therapeutics Inc
26/06/201914:00GlobeNewswire Inc.Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Tri...NASDAQ:GEMPGemphire Therapeutics Inc
18/03/201911:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GEMPGemphire Therapeutics Inc
15/03/201913:00GlobeNewswire Inc.Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial ResultsNASDAQ:GEMPGemphire Therapeutics Inc
14/02/201922:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/12/201814:00GlobeNewswire Inc.Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201822:01GlobeNewswire Inc.Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
24/09/201823:06GlobeNewswire Inc.Gemphire Therapeutics Announces Workforce ReductionNASDAQ:GEMPGemphire Therapeutics Inc
28/08/201816:05Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:GEMPGemphire Therapeutics Inc
22/08/201822:51Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
20/08/201822:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201822:01GlobeNewswire Inc.Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201817:33Dow Jones NewsGemphire Therapeutics Shares Fall Over 50% in Heavy Trading -- Market MoverNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201812:00GlobeNewswire Inc.Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLDNASDAQ:GEMPGemphire Therapeutics Inc
06/08/201822:01GlobeNewswire Inc.Gemphire Announces Amended and Restated Gemcabene License Agreement with Pfizer Inc.NASDAQ:GEMPGemphire Therapeutics Inc
06/08/201822:01GlobeNewswire Inc.Gemphire Provides Update On Development of GemcabeneNASDAQ:GEMPGemphire Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GEMP

La tua Cronologia

NASDAQ
PYLDX
Payden Low Duration Fund...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network